266 related articles for article (PubMed ID: 29426481)
1. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
[TBL] [Abstract][Full Text] [Related]
2. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
4. Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug.
Fabbri J; Pensel PE; Albani CM; Lopez LM; Simonazzi A; Bermudez JM; Palma SD; Elissondo MC
Parasitology; 2020 Aug; 147(9):1026-1031. PubMed ID: 32338226
[TBL] [Abstract][Full Text] [Related]
5. Albendazole-lipid nanocapsules: Optimization, characterization and chemoprophylactic efficacy in mice infected with Echinococcus granulosus.
Ullio Gamboa GV; Pensel PE; Elissondo MC; Sanchez Bruni SF; Benoit JP; Palma SD; Allemandi DA
Exp Parasitol; 2019 Mar; 198():79-86. PubMed ID: 30769018
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis.
Dvoroznáková E; Hrcková G; Borosková Z; Velebný S; Dubinský P
Parasitol Int; 2004 Dec; 53(4):315-25. PubMed ID: 15464441
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
9. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
[TBL] [Abstract][Full Text] [Related]
10. Experimental cystic echinococcosis therapy: In vitro and in vivo combined 5-fluorouracil/albendazole treatment.
Pensel PE; Elissondo N; Gambino G; Gamboa GU; Benoit JP; Elissondo MC
Vet Parasitol; 2017 Oct; 245():62-70. PubMed ID: 28969840
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Oral Bioavailability and Anti-Echinococcosis Efficacy of Albendazole Achieved by Optimizing the "Spring" and "Parachute".
Hu C; Liu Z; Liu C; Li J; Wang Z; Xu L; Chen C; Fan H; Qian F
Mol Pharm; 2019 Dec; 16(12):4978-4986. PubMed ID: 31613633
[TBL] [Abstract][Full Text] [Related]
12. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
[TBL] [Abstract][Full Text] [Related]
13. [Effect of combined pentoxifylline and albendazole against echinococcus multilocularis infection in mice].
Zhou HX; Mo JJ; Chen G; Bao GS; Shi DZ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):333-6. PubMed ID: 17361810
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
15. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885
[TBL] [Abstract][Full Text] [Related]
16. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis.
Shuhua X; Jiqing Y; Mingjie W; Pieying J; Fanghua G; Junjie C; Wei J; Hotez P
Acta Trop; 2002 Apr; 82(1):77-84. PubMed ID: 11904106
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.
Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A
Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401
[TBL] [Abstract][Full Text] [Related]
18. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis.
Farhadi M; Haniloo A; Rostamizadeh K; Ahmadi N
Parasitol Res; 2021 Dec; 120(12):4049-4060. PubMed ID: 34669034
[TBL] [Abstract][Full Text] [Related]
20. Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis.
Permana AD; Paredes AJ; Zanutto FV; Amir MN; Ismail I; Bahar MA; Sumarheni ; Palma SD; Donnelly RF
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38745-38760. PubMed ID: 34353029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]